Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Protein Science : a Publication of the Protein Society|April 8, 2006
A comparative study of available software for high-accuracy homology modeling: from sequence alignments to structural modelsAkbar Nayeem, Doree Sitkoff, Stanley KrystekThe Journal of Chemical Physics|July 9, 2021
Optimized damping parameters for empirical dispersion corrections to symmetry-adapted perturbation theoryJeffrey B Schriber, Dominic A Sirianni, Daniel G A Smith, et al.Bioorganic & Medicinal Chemistry Letters|April 29, 2023
Phthalazinone-based lactams and cyclic ureas as ROCK2 selective inhibitorsZilun Hu, Doree Sitkoff, Peter W Glunz, et al.Bioorganic & Medicinal Chemistry Letters|August 18, 2020
Identification of 5H-chromeno[3,4-c]pyridine and 6H-isochromeno[3,4-c]pyridine derivatives as potent and selective dual ROCK inhibitorsZilun Hu, Cailan Wang, Doree Sitkoff, et al.The Journal of Pharmacology and Experimental Therapeutics|June 12, 2014
Pharmacologic profile of the Adnectin BMS-962476, a small protein biologic alternative to PCSK9 antibodies for low-density lipoprotein loweringTracy Mitchell, Ginger Chao, Doree Sitkoff, et al.ACS Medicinal Chemistry Letters|September 17, 2021
Discovery of BMS-986318, a Potent Nonbile Acid FXR Agonist for the Treatment of Nonalcoholic SteatohepatitisJoseph Carpenter, Gang Wu, Ying Wang, et al.Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenaseDavid S Weinstein, Wen Liu, Zhengxiang Gu, et al.Bioorganic & Medicinal Chemistry Letters|September 15, 2007
Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitorsYan Shi, Doree Sitkoff, Jing Zhang, et al.Journal of Medicinal Chemistry|November 13, 2008
Design, structure-activity relationships, X-ray crystal structure, and energetic contributions of a critical P1 pharmacophore: 3-chloroindole-7-yl-based factor Xa inhibitorsYan Shi, Doree Sitkoff, Jing Zhang, et al.Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitorsYan Shi, Jing Zhang, Mengxiao Shi, et al.Pageof 2